Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Bao

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Frontiers in Cellular and Infection Microbiology|November 26, 2025
Exploring the liver microenvironment following successful therapy for HCV: gene expression profiling and residual T cell infiltrationDaniel E Millian, Esteban Arroyave, Timothy G Wanninger, et al.
Medrxiv : the Preprint Server for Health Sciences|March 3, 2023
Patients with fibrosis from non-alcoholic steatohepatitis have heterogeneous intrahepatic macrophages and therapeutic targetsOmar A Saldarriaga, Santhoshi Krishnan, Timothy G Wanninger, et al.
JHEP Reports : Innovation in Hepatology|January 1, 2024
Heterogeneity in intrahepatic macrophage populations and druggable target expression in patients with steatotic liver disease-related fibrosisOmar A Saldarriaga, Timothy G Wanninger, Esteban Arroyave, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Frontiers in Cellular and Infection Microbiology|November 26, 2025
Exploring the liver microenvironment following successful therapy for HCV: gene expression profiling and residual T cell infiltrationDaniel E Millian, Esteban Arroyave, Timothy G Wanninger, et al.
Medrxiv : the Preprint Server for Health Sciences|March 3, 2023
Patients with fibrosis from non-alcoholic steatohepatitis have heterogeneous intrahepatic macrophages and therapeutic targetsOmar A Saldarriaga, Santhoshi Krishnan, Timothy G Wanninger, et al.
JHEP Reports : Innovation in Hepatology|January 1, 2024
Heterogeneity in intrahepatic macrophage populations and druggable target expression in patients with steatotic liver disease-related fibrosisOmar A Saldarriaga, Timothy G Wanninger, Esteban Arroyave, et al.
Pageof 2